Skip to main content
OpenTrials

Clinical trial condition

Uterine Corpus Malignant Mixed Mesodermal (Mullerian) Tumor

Explore clinical trials studying Uterine Corpus Malignant Mixed Mesodermal (Mullerian) Tumor. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Uterine Corpus Malignant Mixed Mesodermal (Mullerian) Tumor trial results

Recruiting

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

NCT05256225

Conditions
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, +17 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 409 locations
View Trial Details

Related conditions